Biomedical Innovation Program
The Biomedical Innovation Program (BIP) at OHSU is to accelerate the delivery of healthcare technologies from academia to the marketplace and thereby to improve health care. The overarching goal of the program is to foster collaborative translational research that will lead to technology commercialization within a 3-5 year horizon.
To reach this goal, the Biomedical Innovation Program cultivates, evaluates and funds promising translational projects with the objective of moving innovative technologies to clinical application through commercialization.
Do you have an idea for a technical innovation to improve patient care?
Pilot funding is now available; letters of intent are due November 28th, 2013. Read the request for applications.
All applicants and investigators interested in learning more about innovation at the University are strongly encouraged to take advantage of the Innovation Panel Discussion being held November 11th from 3:00 – 4:00 in CHH 3171.
Innovation Panel Discussion
Representatives from the Scientific Review Committee, Technology Transfer & Business Development (TTBD), and Biomedical Engineers (both internal and external to OHSU) will be on hand to answer questions and help applicants work through those aspects of the applications that they may need help on. After the panel discussion there will be an opportunity to allow for focused discussions with the experts. Please RSVP to Colleen Lay at email@example.com.
All registered attendees will be given the opportunity to sign up for 1:1 sessions with experts from the panel from 4:00 – 5:00 on November 11th following the panel discussion.
Our office is open year-round to offer guidance towards developing your idea for future award cycles, and welcomes any interested parties to contact us at any time.
Oregon Clinical and Translational Research Institute
Biomedical Innovation Program, Project Manager